(2-Amino-4,5-dimethylthiophen-3-yl)(4-chlorophenyl)methanone, 95.0%, 25g

2-Bromo-5-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 1g

6-Bromo-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-2-one, 97%, 5g

9-(3-Bromophenyl)carbazole>98.0%(GC)1g

2-Amino-4-phenylpyrimidine>97.0%(GC)(T)5g

2-Bromo-5-ethynylthiophene, 95.0%, 250mg

2-Amino-1,3-propanediol, 97.00%, 5g

Nalpha-(5-Fluoro-2,4-dinitrophenyl)-D-leucinamide [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

5-((1,4-Diazepan-1-yl)sulfonyl)isoquinolin-1(2H)-one, 95.0%, 100mg

NADH sale disodico, 5 g

1-(2-Bromo-5-fluoropyridin-4-yl)ethanone, 95.0%, 250mg

(3S,4S)-tert-Butyl 3,4-bis(hydroxymethyl)pyrrolidine-1-carboxylate, 97%, 250mg

3-Ethyladamantan-1-amine hydrochloride, 95.0%, 1g